USPTO serial 99749921
BREAKTHRU
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALLEN, LACEY M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BREAKTHRU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sarah LeFevre
Sarah LeFevre Gallagher and Kennedy, P.A.2575 E Camelback RdSuite 1100Phoenix, AZ 85016Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development of pharmaceuticals in the field of oncology; Research and development of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical and scientific research in the field of oncology | ACTIVE | Jan 29, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 21, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 21, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 21, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2026 | ALIE | ASSIGNED TO LIE | — |
| Oct 9, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 17, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 17, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 17, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 7, 2026 | NWAP | NEW APPLICATION ENTERED | — |